Daniele et al. 21 reported that multiple myeloma patients with elevated expression of LIG3 mRNA tend to have a worse prognosis, and LIG3 mRNA expression was elevated during disease progression and relapse. This evidence concerns the gene LIG3 and plasma cell myeloma.